Last10K.com

Medmen Enterprises, Inc. (MMNFF) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 25, 2021

Medmen Enterprises, Inc.

HISTORY TOOLS
CIK: 1776932 Ticker: MMNFF
Cover - shares
6 Months Ended
Dec. 25, 2021
Feb. 04, 2022
Cover [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateDec. 25, 2021 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2022 
Current Fiscal Year End Date--06-30 
Entity File Number000-56199 
Entity Registrant NameMEDMEN ENTERPRISES INC. 
Entity Central Index Key0001776932 
Entity Tax Identification Number98-1431779 
Entity Incorporation, State or Country CodeA1 
Entity Address, Address Line One10115 Jefferson Boulevard 
Entity Address, City or TownCulver City 
Entity Address, State or ProvinceCA 
Entity Address, Postal Zip Code90232 
City Area Code(424) 
Local Phone Number330-2082 
Entity Current Reporting StatusNo 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companytrue 
Elected Not To Use the Extended Transition Periodfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 1,200,227,625

View differences made from one quarter to another to evaluate Medmen Enterprises, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Medmen Enterprises, Inc..

Continue

Assess how Medmen Enterprises, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Medmen Enterprises, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Changes In Shareholders' Equity (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Accounts Payable And Accrued Liabilities
Accounts Payable And Accrued Liabilities (Details)
Accounts Payable And Accrued Liabilities (Tables)
Assets Held For Sale
Assets Held For Sale (Details Narrative)
Assets Held For Sale (Details)
Assets Held For Sale (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Derivative Liabilities
Derivative Liabilities (Details 1)
Derivative Liabilities (Details 2)
Derivative Liabilities (Details 3)
Derivative Liabilities (Details Narrative)
Derivative Liabilities (Details)
Derivative Liabilities (Tables)
Discontinued Operations
Discontinued Operations (Details 1)
Discontinued Operations (Details Narrative)
Discontinued Operations (Details)
Discontinued Operations (Tables)
General And Administrative Expenses
General And Administrative Expenses (Details)
General And Administrative Expenses (Tables)
Intangible Assets
Intangible Assets (Details Narrative)
Intangible Assets (Details)
Intangible Assets (Tables)
Inventory
Inventory (Details Narrative)
Inventory (Details)
Inventory (Tables)
Leases
Leases (Details 1)
Leases (Details)
Leases (Tables)
Loss Per Share
Loss Per Share (Details)
Loss Per Share (Tables)
Nature Of Operations
Notes Payable
Notes Payable (Details 1)
Notes Payable (Details Narrative)
Notes Payable (Details)
Notes Payable (Tables)
Other Operating Expense
Other Operating Expense (Details)
Other Operating Expense (Tables)
Property And Equipment
Property And Equipment (Details Narrative)
Property And Equipment (Details)
Property And Equipment (Tables)
Provision For Income Taxes And Deferred Income Taxes
Provision For Income Taxes And Deferred Income Taxes (Details Narrative)
Provision For Income Taxes And Deferred Income Taxes (Details)
Provision For Income Taxes And Deferred Income Taxes (Tables)
Related Party Transactions
Related Party Transactions (Details Narrative)
Revenue
Revenue (Details)
Revenue (Tables)
Segment Information
Senior Secured Convertible Credit Facility
Senior Secured Convertible Credit Facility (Details )
Senior Secured Convertible Credit Facility (Details 1)
Senior Secured Convertible Credit Facility (Details Narrative)
Senior Secured Convertible Credit Facility (Tables)
Share-Based Compensation
Share-Based Compensation (Details 1)
Share-Based Compensation (Details 2)
Share-Based Compensation (Details 3)
Share-Based Compensation (Details 4)
Share-Based Compensation (Details 5)
Share-Based Compensation (Details 6)
Share-Based Compensation (Details Narrative)
Share-Based Compensation (Details)
Share-Based Compensation (Tables)
Shareholders Equity (Details 1)
Shareholders' Equity (Details 2)
Shareholders' Equity (Details)
Shareholders??? Equity
Shareholders??? Equity (Details Narrative)
Shareholders??? Equity (Tables)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)

Material Contracts, Statements, Certifications & more

Medmen Enterprises, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: MMNFF
CIK: 1776932
Form Type: 10-Q Quarterly Report
Accession Number: 0001829126-22-003192
Submitted to the SEC: Tue Feb 08 2022 9:30:00 AM EST
Accepted by the SEC: Tue Feb 08 2022
Period: Saturday, December 25, 2021
Industry: Retail Stores

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mmnff/0001829126-22-003192.htm